You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

genes BRCA1

Showing 1 - 25 of 9,088
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

Completed
  • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
  • Stockholm, Sweden
    Department of Woman and Child Health Karolinska University Hospi
Jan 15, 2022

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Genes Contributing to Hereditary Ovarian Cancer in Women and

Completed
  • Ovarian Cancer
    • Seattle, Washington
      University of Washington
    Feb 2, 2022

    HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

    Completed
    • Epithelial Ovarian Cancer
    • +6 more
    • Evaluation of homologous recombination deficiency score
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022

    Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

    Not yet recruiting
    • Recurrent Metastatic Melanoma
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Jul 29, 2022

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

    Not yet recruiting
    • Metastatic Malignant Solid Neoplasm
    • Unresectable Malignant Solid Neoplasm
    • Biopsy
    • +2 more
    • (no location specified)
    Jan 14, 2023

    BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer Trial in Napoli (Olaparib tablets)

    Recruiting
    • BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
    • Olaparib tablets
    • Napoli, Italy
      Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento
    Mar 3, 2021

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      BRCA Gene Rearrangement Trial in Seoul (BRCA 1, Chemotherapy)

      Completed
      • BRCA Gene Rearrangement
      • Seoul, Korea, Republic of
        Chung-Ang University College of Medicine
      Jan 25, 2021

      Germline Variant Carriers With BRCA1 or BRCA2

      Recruiting
      • BRCA1 and/or BRCA2 Variant Carriers
      • +3 more
        • Okayama, Japan
          Okayama University
        Dec 25, 2022

        Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

        Recruiting
        • Metastatic or Unresectable Melanoma
        • Cleveland, Ohio
          Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
        Mar 22, 2022

        Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

        Not yet recruiting
        • Breast Cancer
        • Questionnaires
        • Communication of the results of the BRCA1/2 ultra rapid test
        • (no location specified)
        Oct 26, 2023

        Locally Advanced or Metastatic Solid Tumors, Genes, BRCA 1 Trial in Worldwide (Avelumab, Talazoparib)

        Active, not recruiting
        • Locally Advanced or Metastatic Solid Tumors
        • Genes, BRCA 1
        • Palo Alto, California
        • +89 more
        Jan 18, 2023

        BRCA1/2 Flu Vaccine

        Active, not recruiting
        • BRCA1 Mutation
        • BRCA2 Mutation
        • Seasonal influenza vaccine
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Aug 16, 2022

        Identification of a Genetic Predisposition to ProstAte Cancer

        Active, not recruiting
        • Prostate Cancer in BRCA1 and BRCA2 Carriers
        • PSA test
        • Prostate Biopsy
        • Sutton, Surrey, United Kingdom
          Cancer Genetics Unit, Royal Marsden Hospital
        Mar 30, 2022

        InheriteD brEast caNcer iTalian regIsTrY A

        Recruiting
        • Breast Cancer
          • Aviano, Pordenone, Italy
          • +11 more
          Apr 26, 2023

          Searching for Novel Germline Mutations in Lobular Breast Cancer

          Recruiting
          • Lobular Breast Carcinoma
          • +3 more
          • Illumina panel
          • Milan, Italy
            European Institute of Oncology
          Sep 12, 2022

          Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

          Recruiting
          • Breast Cancer
          • Genetic Predisposition
          • Genetic predisposition to breast cancer
          • Rome, Italy
          • +1 more
          May 4, 2023

          BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

          Active, not recruiting
          Has Results
          • BRCA1 Gene Mutation
          • +5 more
          • Durvalumab
          • +3 more
          • Buffalo, New York
          • +1 more
          Jan 20, 2023

          Molecular Profiling in Prostate Cancer

          Recruiting
          • Prostate Cancer Metastatic
          • +4 more
          • Tumor molecular profiling
          • Athens, Greece
            Hellenic Cooperative Oncology Group
          Mar 15, 2022

          Advanced Breast Cancer Trial in Spain (Olaparib)

          Completed
          • Advanced Breast Cancer
          • Badalona, Barcelona, Spain
          • +15 more
          Jan 12, 2023

          Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

          Not yet recruiting
          • Advanced Malignant Solid Neoplasm
          • +2 more
          • Biopsy
          • +5 more
          • (no location specified)
          Apr 8, 2023